[11C]-( )-PHNO
Showing 1 - 25 of >10,000
Cocaine Dependence Trial in New Haven (Methylphenidate, Alpha Methyl Para Tyrosine (AMPT), [11C]PHNO)
Terminated
- Cocaine Dependence
- Methylphenidate
- +3 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Feb 24, 2021
Alcohol Use Disorder Trial in Toronto ([11C]-(+)-PHNO PET scan, Alcohol Self-Administration, Craving Task)
Completed
- Alcohol Use Disorder
- [11C]-(+)-PHNO PET scan
- +4 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Oct 27, 2020
Nicotine Dependence, Healthy Trial in New Haven (Amphetamine)
Completed
- Nicotine Dependence
- Healthy
-
New Haven, ConnecticutYale University
Mar 4, 2020
Healthy Volunteers Trial in London (Amphetamine, TAK -041, [11C] (+)-4-propyl-(+)-4-propyl-9-hydroxynaphthoxazine (PHNO))
Completed
- Healthy Volunteers
- Amphetamine
- +2 more
-
London, United KingdomHammersmith Medicines Research
Mar 17, 2021
Inflammation in Alzheimer's Disease and Related Dementias Using
Recruiting
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Nov 9, 2023
Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)
Completed
- Ketoses, Metabolic
- Observational heart and kidney on siemens TEP scan
-
Sherbrooke, Quebec, CanadaResearch Center on Aging
Jan 16, 2023
ALS Trial ([11C]CPPC PET ligand)
Not yet recruiting
- ALS
- [11C]CPPC PET ligand
- (no location specified)
Jan 9, 2023
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)
Active, not recruiting
- Tauopathies
- 11C-HY-2-15 PET
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 6, 2023
11C-para-aminobenzoic Acid
Recruiting
- Renal Excretion
- +3 more
- 11C-para-aminobenzoic acid PET/CT
- Probenecid
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jan 30, 2023
Crohn's Disease Trial in Stockholm (AZD7798, [11C]AZ14132516)
Not yet recruiting
- Crohn's Disease
-
Stockholm, SwedenResearch Site
Sep 22, 2023
Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism, Adrenal Tumors Trial in Singapore
Recruiting
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- +2 more
- 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
-
Singapore, Singapore
- +6 more
Oct 26, 2023
Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
Not yet recruiting
- Huntington Disease
- [11C]UCB-J
- [18F]SynVest-1
-
Leuven, BelgiumUZ Leuven
Nov 2, 2022
Diabetes, Type 2, Heart Failure, Healthy Trial in Aarhus N (3-[11C]-OHB)
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- 3-[11C]-OHB
-
Aarhus N, Jutland, DenmarkAarhus University Hospital
Nov 1, 2022
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)
Active, not recruiting
- Melanoma
- FDG PET/CT scan
- +3 more
-
Chapel Hill, North Carolina
- +1 more
Jan 10, 2023
Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)
Recruiting
- Cocaine Use Disorder
- Baseline [C-11]NPA PET Scan
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh
Jun 27, 2022
MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)
Recruiting
- Major Depressive Disorder
- Toludivenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 14, 2023
CNS Tumor, Head and Neck Tumors Trial in Memphis (L-(11C) methionine)
Available
- Central Nervous System Tumor
- Head and Neck Neoplasms
- L-(11C) methionine
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 19, 2022
Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.
Completed
- Huntington Disease
- [11C]CHDI-00485180-R
- [11C]CHDI-00485626
-
Leuven, BelgiumUZ Leuven
May 18, 2022
Mild Cognitive Impairment Trial in Winston-Salem ([11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan)
Enrolling by invitation
- Mild Cognitive Impairment
- [11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan
-
Winston-Salem, North CarolinaWake Forest School of Medicine
Dec 22, 2022
Amyotrophic Lateral Sclerosis Trial in Baltimore ([11C]CPPC Injection)
Recruiting
- Amyotrophic Lateral Sclerosis
- [11C]CPPC Injection
-
Baltimore, MarylandJohns Hopkins Outpatient Center
Jul 11, 2022
Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)
Recruiting
- Lymphangioleiomyomatosis
- Tuberous Sclerosis Complex
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2022